Proteoglycan metabolism, cell death and Kashin-Beck Disease

Kashin-Beck Disease (KBD) is an endemic, chronic and degenerative osteoarthropathy principally occurring in children. The characteristic pathological change of KBD is chondrocyte necrosis in hyaline articular cartilage. Proteoglycans are one of the major components in the extracellular matrix of articular cartilage, and disrupted proteoglycan metabolism and loss of proteoglycans in articular cartilage from KBD patients has been observed. In this mini-review, we discuss the close relationship between chondrocyte death including necrosis and loss of proteoglycan, and its potential mechanism during KBD onset and development, which may provide new clues for KBD research.

[1]  A. Yee,et al.  Structure and function of aggrecan , 2002, Cell Research.

[2]  Markus A. Wimmer,et al.  The Influence of Mechanical Stimuli on Articular Cartilage Tissue Engineering , 2006 .

[3]  Xiong Guo,et al.  Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease. , 2006, The Journal of rheumatology.

[4]  T. Aigner,et al.  Chondroptosis: A variant of apoptotic cell death in chondrocytes? , 2004, Apoptosis.

[5]  M. Sharif,et al.  Chondrocyte apoptosis: a cause or consequence of osteoarthritis? , 2011, International journal of rheumatic diseases.

[6]  A. I. Nesterov.  THE CLINICAL COURSE OF KASHIN-BECK DISEASE. , 1964, Arthritis and rheumatism.

[7]  W. Yin,et al.  Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling Pathways* , 2009, The Journal of Biological Chemistry.

[8]  J. Buckwalter,et al.  Antioxidants block cyclic loading induced chondrocyte death. , 2007, The Iowa orthopaedic journal.

[9]  J. Kerr,et al.  An electron‐microscope study of the mode of cell death induced by cancer‐chemotherapeutic agents in populations of proliferating normal and neoplastic cells , 1975, The Journal of pathology.

[10]  Zong-ke Zhou,et al.  Serum levels of IL‐1β, IL‐6 and TNF‐α in rats fed with Kashin‐Beck disease‐affected diet , 2010, International journal of rheumatic diseases.

[11]  W. Dong,et al.  Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin–Beck disease , 2010, Clinical Rheumatology.

[12]  Chen Duan,et al.  Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. , 2010, Arthritis and rheumatism.

[13]  H. Steinbrenner,et al.  Selenium, oxidative stress, and health aspects. , 2005, Molecular aspects of medicine.

[14]  Wei Wang,et al.  Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin–Beck disease using T-2 toxin and selenium deficiency conditions , 2011, Rheumatology International.

[15]  D L Bader,et al.  The influence of mechanical loading on isolated chondrocytes seeded in agarose constructs. , 2000, Biorheology.

[16]  Xiong Guo,et al.  [Chondrocyte apoptosis and the expression of Bcl-2, Bax, Fas and iNos in articular cartilage in Kashin-Beck disease]. , 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[17]  C. Chen,et al.  Oxidant damage in Kashin‐Beck disease and a rat Kashin‐Beck disease model by employing T‐2 toxin treatment under selenium deficient conditions , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[18]  Xiong Guo,et al.  [Serum hyaluronic acid, tumor necrosis factor -alpha, vascular endothelial growth factor, NO, and Se levels in adult patients with Kashin-Beck disease]. , 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[19]  J. Zwerina,et al.  The lonely death: Chondrocyte apoptosis in TNF-induced arthritis , 2007, Autoimmunity.

[20]  R. Stone.  Diseases. A medical mystery in middle China. , 2009, Science.

[21]  Jian Li,et al.  A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin–Beck disease of the knee , 2012, Clinical Rheumatology.

[22]  B. Caterson,et al.  Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. , 2008, Osteoarthritis and cartilage.

[23]  W. Horton,et al.  Cartilage viability after repetitive loading: a preliminary report. , 2002, Osteoarthritis and cartilage.

[24]  L. Weimin,et al.  Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials. , 2012, Osteoarthritis and cartilage.

[25]  Ming Yang,et al.  Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study. , 2012, Osteoarthritis and cartilage.

[26]  C. Wang,et al.  Interaction between fulvic acids of different origins and active oxygen radicals. , 1996, Science in China. Series C, Life sciences.

[27]  P. Nicotera,et al.  Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis , 1997, The Journal of experimental medicine.

[28]  I. Szleifer,et al.  Structure and interactions of aggrecans: statistical thermodynamic approach. , 2008, Biophysical journal.

[29]  Jian Li,et al.  Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China , 2012, Rheumatology International.

[30]  D. Grennan,et al.  Comparison of urinary glycosaminoglycan excretion in rheumatoid arthritis, osteoarthritis, myocardial infarction, and controls. , 1986, Annals of the rheumatic diseases.

[31]  Wei Wang,et al.  Down-regulated HS6ST2 in osteoarthritis and Kashin-Beck disease inhibits cell viability and influences expression of the genes relevant to aggrecan metabolism of human chondrocytes. , 2011, Rheumatology.

[32]  Xiong Guo,et al.  [Expression of Caspase-8 and Bcl-2 in the cartilage loose bodies in patients with Kashin-Beck disease]. , 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[33]  D. D’Lima,et al.  Cell death in cartilage. , 2004, Osteoarthritis and cartilage.

[34]  K. Choe,et al.  Apoptotic chondrocyte death in human osteoarthritis. , 2000, The Journal of rheumatology.

[35]  Linda Troeberg,et al.  Proteases involved in cartilage matrix degradation in osteoarthritis. , 2012, Biochimica et biophysica acta.

[36]  Ming Ling,et al.  [Expression of interleukin-1beta and tumor necrosis factor-alpha in the synovium and synovial fluid of patients with Kashin-Beck disease and osteoarthritis]. , 2009, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[37]  Xiong Guo,et al.  [Comparison of apoptosis of articular chondrocytes in the pathogenesis of Kashin-beck disease and primary osteoarthritis]. , 2006, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[38]  Krishna Dalal,et al.  ADAMTS‐4 and ADAMTS‐5: Key enzymes in osteoarthritis , 2011, Journal of cellular biochemistry.

[39]  L. Sokoloff.  Acquired chondronecrosis. , 1990, Annals of the rheumatic diseases.

[40]  B. Caterson.  Fell‐Muir Lecture: Chondroitin sulphate glycosaminoglycans: fun for some and confusion for others , 2012, International journal of experimental pathology.

[41]  Xiong Guo,et al.  [Changes of the content of Se and the levels of several cytokines in the serum of patients with Kaschin-Beck disease]. , 2007, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[42]  M. Lotz,et al.  Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. , 1998, Arthritis and rheumatism.

[43]  Q. Gong,et al.  Measurement of the bioactivity of interleukin and tumour necrosis factor in synovial fluid of Kashin-Beck disease , 2001, International Orthopaedics.

[44]  B Kurz,et al.  Biosynthetic response and mechanical properties of articular cartilage after injurious compression , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[45]  P. Nicotera,et al.  Apoptosis and necrosis: different execution of the same death. , 1999, Biochemical Society symposium.

[46]  Wei Wang,et al.  Effects of T-2 toxin and selenium on chondrocyte expression of matrix metalloproteinases (MMP-1, MMP-13), α2-macroglobulin (α2M) and TIMPs. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[47]  Dean Y. Li,et al.  Detection of Unsaturated Disaccharides, Pyridinoline, and Hydroxyproline in Urine of Patients with Kashin-Beck Disease: Comparison with Controls in an Endemic Area , 2009, The Journal of Rheumatology.

[48]  Xiong Guo,et al.  [Protective effect of selenium against T-2 toxin-induced inhibition of chondrocyte aggrecan and collagen II synthesis]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[49]  W. Zhang,et al.  Selenium, iodine and fungal contamination in Yulin District (People's Republic of China) endemic for Kashin-Beck disease , 2001, International Orthopaedics.

[50]  K. Ansari,et al.  Effects of trichothecene mycotoxins on eukaryotic cells: A review , 2005, Food additives and contaminants.

[51]  K. Ahmadi,et al.  Effects of T-2 toxin on cytokine production by mice peritoneal macrophages and lymph node T-cells. , 2008, Iranian journal of immunology : IJI.

[52]  V. Kéry,et al.  Urinary glycosaminoglycan excretion in rheumatic diseases. , 1992, Clinical chemistry.

[53]  B. Caterson,et al.  Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect , 2007, Journal of Zhejiang University SCIENCE B.